Effects of mycophenolate mofetil and lisinopril on collagen deposition in unilateral ureteral obstruction in rats

American Journal of Nephrology

Volumn 24, Issue 5, 2004, Pages 527-536

  Gonçalves, Rômulo G ^a   Biato, Marco A ^a   Colosimo, Ricardo D G ^a   Martinusso, Cesônia A ^a   Pecly, Inah D ^a   Farias, Eliene K ^a   Cardoso, Lúcio R ^a   Takiya, Christina M ^a   Ornellas, José F R ^a   Leite Jr , Maurilo ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Univ Federal do Rio de Janeiro ^*  (Brazil)

Author keywords

Collagen; Fibrosis; Hydronephrosis; Macrophages; Myofibroblast; Ureteral obstruction

Indexed keywords

ACID; ALPHA ACTIN; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EOSIN; HEMATOXYLIN; HYDROXYPROLINE; LISINOPRIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SCHIFF BASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL VOLUME; CHEMICAL REACTION; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; EXAMINATION; FIBROGENESIS; FRAGMENTATION REACTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; MACROPHAGE; MORPHOMETRICS; MYOFIBROBLAST; NONHUMAN; OBSERVATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; URETER OBSTRUCTION; URETER SURGERY;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; COLLAGEN; FEMALE; KIDNEY; LISINOPRIL; MYCOPHENOLIC ACID; RATS; RATS, WISTAR; URETERAL OBSTRUCTION;

EID: 10644237773     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081706     Document Type: Article

References (29)

1. Curham GC, Zeidel ML: Urinary tract obstruction; in Brenner BM, Rector FC (eds): The Kidney, ed 6. Philadelphia, Saunders, 1996, vol 2, pp 1936-1958.
2. Klahr S: New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991;18:689-699.
3. Klahr S, Morrissey J: Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283:F861-F875.
4. Moody TE, Vaughan ED, Wyker AT, Gillenwater JY: The role of intrarenal angiotensin II in the hemodynamic response to unilateral obstructive nephropathy. Invest Urol 1977;14:390-397.
5. Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H: Quantification of TGF-beta 1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 2001;281:F513-F521.
6. Diamond JR, Ricardo SD, Klahr S: Mechanisms of interstitial fibrosis in obstructive nephropathy. Semin Nephrol 1998;18:612-621.
7. Chung KH, Gomez RA, Chevalier RL: Regulation of renal growth factors and clusterin by AT1 receptors during neonatal ureteral obstruction. Am J Physiol 1995;268:F1117-F1123.
8. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction. Kidney Int 1995;47:1285-1294.
9. Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S: Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994;45:1637-1647.
10. el-Dahr SS, Gomez RA, Khare G, Peach MJ, Carey RL, Chevalier RL: Expression of renin and its mRNA in the adult rat kidney with chronic ureteral obstruction. Am J Kidney Dis 1990;15:575-582.
11. Romero F, Rodriguez-Iturbe B, Parra G, Gonzalez L, Herrera-Acosta J, Tapia E: Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats. Kidney Int 1999;55:945-955.
12. Badid C, Vincent M, McGregor B, Melin M, Hadj-Aissa A, Veysseyre C, Hartmann DJ, Desmouliere A, Laville M: Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney. Kidney Int 2000;58:51-61.
13. Bayazit AK, Bayazit Y, Noyan A, Gonlusen G, Anarat A: Comparison of mycophenolate mofetil and azathioprine in obstructive nephropathy. Pediatr Nephrol 2003;18:100-104.
14. Zhang C, Zhu Z, Wang G, Deng A: Effects of mycophenolate mofetil on renal interstitial fibrosis after unilateral ureteral obstruction in rats. J Huazhong Univ Sci Technol Med Sci 2003;23:269-270, 282.
15. Beharrie A, Franc-Guimond J, Rodriguez MM, Au J, Zilleruelo G, Abitbol CL: A functional immature model of chronic partial ureteral obstruction. Kidney Int 2004;65:1155-1161.
16. Dolber PC, Spach MS: Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 1993;41:465-469.
17. Moller JC, Skriver E: Quantitative ultrastructure of human proximal tubules and cortical interstitium in chronic renal disease (hydronephrosis). Virchows Arch A Pathol Anat Histopathol 1985;406:389-406.
18. Stegemann H, Stalder K: Determination of hydroxyproline. Clin Chim Acta 1967;18:267-273.
19. Kaneto H, Morrissey J, Klahr S: Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993;44:313-321.
20. Klahr S, Morrissey J: Angiotensin II and gene expression in the kidney. Am J Kidney Dis 1998;31:171-176.
21. Sakai T, Kawamura T, Shirasawa T: Mizoribine improves renal tubulointerstitial fibrosis in unilateral ureteral obstruction (UUO)-treated rat by inhibiting the infiltration of macrophages and the expression of alpha-smooth muscle actin. J Urol 1997;158:2316-2322.
22. Antus B, Exton MS, Rosivall L: Angiotensin II: A regulator of inflammation during renal disease? Int J Immunopathol Pharmacol 2001;14:25-30.
23. Wu LL, Yang N, Roe CJ, Cooper ME, Gilbert RE, Atkins RC, Lan HY: Macrophage and myofibroblast proliferation in remnant kidney: Role of angiotensin II. Kidney Int Suppl 1997;63:S221-S225.
24. Weber KT: Fibrosis, a common pathway to organ failure: Angiotensin II and tissue repair. Semin Nephrol 1997;17:467-491.
25. Jerningan SM, Eddy AA: Experimental insights into the mechanisms of tubulo-interstitial scarring; in El Nahas M, Harris K, Anderson S (eds): Mechanisms and Clinical Management of Chronic Renal Failure. Oxford, Oxford University Press, 2000, pp 104-145.
26. Yang J, Liu Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001;159:1465-1475.
27. Vaday GG, Schor H, Rahat MA, Lahat N, Lider O: Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes. J Leukoc Biol 2001;69:613-621.
28. Philips N, Keller T, Gonzalez S: TGF beta-like regulation of matrix metalloproteinases by anti-transforming growth factor-beta, and anti-transforming growth factor-beta 1 antibodies in dermal fibroblasts: Implications for wound healing. Wound Repair Regen 2004;12:53-59.
29. Noronha IL, Fujihara CK, Oliveira IB, Leitão TG, Zatz R: Enhanced interstitial expression of angiotensin II and TGF β in the renal ablation model: Effect of mycophenolate mofetil. J Am Soc Nephrol 1998;9:618A.